Europace Advance Access originally published online on September 13, 2007
Europace 2007 9(11):1069-1072; doi:10.1093/europace/eum185
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABLATION
Radiofrequency ablation of an epicardial ventricular tachycardia through the great cardiac vein in a patient with mitro-aortic mechanical prostheses
Electrophysiology and Pacing/Defibrillation Department, Clinique Pasteur, 43–45, Avenue de Lombez, 31076 Toulouse, France
Manuscript submitted 29 May 2007. Accepted after revision 6 August 2007.
* Corresponding author. Tel: +33 56221645; fax: +33 562211641.E-mail address: j.albenque{at}clinique-pasteur.com
| Abstract |
|---|
|
|
|---|
Aims: Prior cardiac surgery limits epicardial ventricular tachycardia (VT) ablation due to epicardial adhesions formation.
Methods and results: We describe an epicardial VT ablation through the coronary venous system in a patient with mechanical mitro-aortic prostheses. The different possible ablation approaches and their potential limitations are discussed.
Conclusion: In selected patients, especially after cardiac surgery, coronary venous system approach can be considered as a safety possible approach for the ablation of some epicardial VTs.
Key Words: Epicardial ventricular tachycardia, Ablation, Great cardiac vein, Mitro-aortic mechanical prostheses
| Introduction |
|---|
|
|
|---|
Cardiac surgery is a source of epicardial adhesions which can subsequently limit access into the pericardial space for epicardial ventricular tachycardia (VT) ablation.
Furthermore, mechanical mitro-aortic prostheses preclude catheter access to the left ventricle.
In this setting, we describe the radiofrequency (RF) catheter ablation of an epicardial VT through the coronary venous system, in a patient who had underwent mitro-aortic valves replacement using mechanical prostheses.
| Clinical presentation |
|---|
|
|
|---|
A 60-year-old woman was referred to our institution for RF catheter ablation of a presyncopal, drug resistant, recurrent, and monomorphic VT with a cycle length of 380 ms. The patient underwent mitro-aortic valves replacement using mechanical prostheses coupled to surgical atrial fibrillation ablation 3 months prior to admission. In addition, she had a prior history of amiodarone-related hyperthyroidism. Laboratory samples and preoperatory (mitro-aortic valves surgery) coronary angiogram were deemed normal. Left ventricular ejection fraction and other echocardiographic parameters were within the normal range. The VT had right bundle branch block morphology, inferior axis, and a slurred initial deflection consistent with a pseudo-delta-wave (Figure 1A). Three days before the procedure, warfarin was stopped and heparin was initiated. Anti-arrhythmic medications were discontinued five half-lives before the procedure. After written informed consent was obtained, an electrophysiological study was performed in the postabsortive state under light sedation. Four hours before the procedure, aPTT, PT, and INR were 76 s, 58%, and 1.5, respectively. From the beginning of the study, frequent monomorphic premature ventricular contractions (PVCs) with the same characteristics of the VT, including couplets and triplets, were recorded. Of note, the patient had a rate-controlled left atrial flutter since the surgical AF ablation procedure was not completely effective. A 7 F irrigated-tip catheter (SPRINKLARTM Medtronic, Inc., Minneapolis, MN, USA) was inserted through the right femoral vein and used for mapping and ablation purpose. Surface ECG and bipolar endocardial electrograms were continuously monitored and stored on a computer-based digital amplifier/recorded system (LabSystem Pro, Bard Electrophysiology, Lowell, MA, USA). Intracardiac electrograms were filtered from 30 to 500 Hz and measured with online calipers at 25–200 mm/s. Targeting PVCs was chosen as the ablation strategy due to the poor tolerance of the clinical VT. Mapping was performed at the RVOT and above the pulmonary valves. Both activation analysis during PVCs and pacemapping at those sites were poor. Indirect mapping of the LV was then performed through the CS. During PVCs, local activation was the earliest at the distal aspect of the great cardiac vein (GCV) (Figure 2), preceding the onset of the QRS complex by 15 ms. A fragmented potential was recorded at that site during PVCs (Figure 3) and pacemapping provided an identical (12/12) match with the VT morphology (Figure 1B). A single RF application at the distal aspect of the GCV (40°C, 20 W, 20 ml/mn) definitively eliminated PVCs (Figure 4). Afterwards, ventricular stimulation with and without isoproterenol infusion failed to induce any VT. ECG monitoring showed no ST-segment changes during or after RF energy application, and an echocardiographic control showed no pericardial effusion. Warfarin was re-initiated 6 h after the procedure. Heparin was stopped 3 days later when INR was 3.5. After the procedure, 24 h Holter monitoring showed neither PVCs nor VT. The patient has remained arrhythmia-free during the 9 months period of follow-up.
|
|
|
|
| Discussion |
|---|
|
|
|---|
Although the VT of our patient fulfilled the criteria described by Berruezo et al.1
34 ms in precordial leads, intrinsicoid deflection time
85 ms in V2, and RS complex duration
121 ms in any precordial lead), suggesting an epicardial origin, pericardial access, as described by Sosa et al.2
In patients referred for left-sided VT catheter ablation, when the ECG is suggestive of a pericardial circuit, after confirming the fact that the VT has no critical endocardial participation, it could be interesting to map at first through the coronary venous system in order to determine if the critical component of the circuit can be reached through the coronary venous system. If this is the case, one can attempt to ablate the VT by this approach, which is feasible and safe.5
Conversely, if the mapping is disappointing or the circuit not reachable due to anatomical limitations, then a pericardial approach as described by Sosa et al.2
or another type of pericardial approach3
can be applied depending on the characteristics of the patient and his clinical history.
| Conclusion |
|---|
|
|
|---|
In selected patients, especially after cardiac surgery, the coronary venous system can be considered as a potential approach for the ablation of epicardial VT. However, it is paramount to recognize that epicardial VT RF ablation through the coronary venous system is limited by the accessibility of only certain segments of the LV and can only be applied to a limited number of patients.
| Funding |
|---|
|
|
|---|
Dr Bortone is the recipent of a fellowship scolarship (grant) from Biosense-Webster, Inc. For his trainee at the Clinique Pasteur, Toulouse France. Dr Bortone has no commercial relationship with Biosense. Webster Inc.
Conflict of interest: A.B. is the recipient of a Fellowship grant from Biosense-Webster.
| References |
|---|
|
|
|---|
[1] Berruezo A, Mont L, Nava S, Chueca E, Bartholomay E, Brugada J. Electrocardiographic recognition of the epicardial origin of ventricular tachycardias. Circulation (2004) 109:1842–7.
[2] Sosa E, Scanavacca M, d'Avila A, Pilleggi F. A new technique to perform epicardial mapping in electrophysiology laboratory. J Cardiovasc Electrophysiol (1996) 7:531–6.[Web of Science][Medline]
[3] Soejima K, Couper G, Cooper JM, Sapp JL, Epstein LM, Stevenson WG. Subxiphoid surgical approach for epicardial catheter-based mapping and ablation in patients with prior cardiac surgery or difficult pericardial access. Circulation (2004) 110:1197–201.
[4] Anh DJ, Hsia HH, Reitz B, Zei P. Epicardial ablation of postinfarction ventricular tachycardia with an externally irrigated catheter in a patient with mechanical and mitral valves. Heart Rhythm (2007) 4:651–4.[CrossRef][Web of Science][Medline]
[5] Obel OA, d'Avila A, Neuzil P, Saad EB, Ruskin JN, Reddy VY. Ablation of left ventricular epicardial outflow tract tachycardia from the distal great cardiac vein. J Am Coll Cardiol (2006) 48:1813–7.
[6] Josephson ME, Horowitz LN, Waxman HL, Cain ME, Spielman SR, Greenspan AM, et al. Sustained ventricular tachycardia: role of the 12-lead electrocardiogram in localizing site of origin. Circulation (1981) 64:257–71.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



